Zydus Lifesciences Announces Special Window for Re-lodgement of Physical Share Transfers

Zydus Lifesciences Limited has announced a special window for the re-lodgement of transfer requests for physical shares. This initiative is in accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD...

Zydus Lifesciences Limited has announced a special window for the re-lodgement of transfer requests for physical shares. This initiative is in accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 02, 2025. The special window will be open for a period of six months, commencing from July 7, 2025, and concluding on January 6, 2026. This facility is specifically for transfer requests that were lodged prior to April 1, 2019, and were subsequently rejected or returned to the lodger due to deficiencies in documentation or processing. Investors who may have missed the earlier deadline of March 31, 2021, can now re-lodge their transfer requests. They need to furnish the necessary documents to the Company or its Registrar to an Issue and Share Transfer Agent (RTA), MUFG Intime India Private Limited. Transferred shares will only be issued in demat mode after the documents are verified and found in order by the RTA. The lodger must possess a demat account with CDSL or NSDL to receive the shares in demat form. Transfer requests lodged after January 6, 2026, will not be accepted by the Company or the RTA. The publication regarding this special window was made in the Financial Express (English and Gujarati editions) on December 27, 2025.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Zydus Lifesciences Limited in the news today?

Zydus Lifesciences Limited (ZYDUSLIFE) is in the news due to the announcement is a procedural update regarding share transfers and does not inherently contain positive or negative financial news.

Share Transfer UpdatesOther Regulatory Filings
Zydus Lifesciences LimitedZYDUSLIFEhttps://prysm.fi/v2/analyze/ZYDUSLIFE

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Zydus Lifesciences Announces Special Window for Re-lodgement of Physical Share Transfers

December 27, 2025, 09:17 AM

AI Sentiment Analysis

Top Queries to Ask About Zydus Lifesciences Limited

Zydus Lifesciences Limited has announced a special window for the re-lodgement of transfer requests for physical shares. This initiative is in accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 02, 2025.

The special window will be open for a period of six months, commencing from July 7, 2025, and concluding on January 6, 2026. This facility is specifically for transfer requests that were lodged prior to April 1, 2019, and were subsequently rejected or returned to the lodger due to deficiencies in documentation or processing.

Investors who may have missed the earlier deadline of March 31, 2021, can now re-lodge their transfer requests. They need to furnish the necessary documents to the Company or its Registrar to an Issue and Share Transfer Agent (RTA), MUFG Intime India Private Limited. Transferred shares will only be issued in demat mode after the documents are verified and found in order by the RTA. The lodger must possess a demat account with CDSL or NSDL to receive the shares in demat form.

Transfer requests lodged after January 6, 2026, will not be accepted by the Company or the RTA. The publication regarding this special window was made in the Financial Express (English and Gujarati editions) on December 27, 2025.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Zydus Lifesciences Limited

Discover more trending news on Prysm

View All